MetLife Investment Management’s Biomea Fusion BMEA Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEA
CAM
BBA
ACM
MetLife Investment Management's BMEA Position: Q4 2024 in Review
MetLife Investment Management sold out of Biomea Fusion (BMEA) in Q4 2024, closing a stake of 16,701 shares — an estimated $169K sold.
MetLife Investment Management first reported a position in BMEA in Q2 2023 and held it in 6 quarters. The position peaked at $234K in Q2 2023. 108 funds tracked by Wall St. Rank hold BMEA as of Q4 2024.
- MetLife Investment Management reported no remaining Biomea Fusion position as of Q4 2024 after selling out during the quarter.
- MetLife Investment Management sold 16,701 Biomea Fusion shares in Q4 2024, an estimated $169K.
- MetLife Investment Management first reported a position in Biomea Fusion in Q2 2023 and held it in 6 quarters.
- MetLife Investment Management's Biomea Fusion position peaked at $234K in Q2 2023.
- 108 funds tracked by Wall St. Rank held Biomea Fusion as of Q4 2024.
Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.